Outcome of non-surgical treatment of proximal femur fractures in the fragile elderly population.


Journal

Injury
ISSN: 1879-0267
Titre abrégé: Injury
Pays: Netherlands
ID NLM: 0226040

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 24 02 2019
revised: 17 05 2019
accepted: 21 05 2019
pubmed: 31 5 2019
medline: 25 2 2020
entrez: 31 5 2019
Statut: ppublish

Résumé

With the aging of the population the rate of fragility hip fractures increases. While medical recommendations are for hasten surgical treatment, for some older patients burdened with severe comorbidities, this might be risky. To compare the outcomes of patients treated non-surgically to those of the most fragile patients treated surgically. A retrospective cohort study, of individuals aged ≥65 years who presented with fragility hip fractures between 01.01.2011-30.06.2016, to a primary trauma center. Patients treated surgically were stratified according to their age-adjusted Charlsons' comorbidity index (ACCI) score. Patients in the upper third of ACCI score, representing the more fragile population, were compared to patients treated non-surgically. 847 patients presented with fragility fractures. 94 (11%) were treated non-surgically and 753 (89%) underwent surgery. Medical reasons were the leading cause for non-surgical treatment (61.7%). Surgically-treated patients were stratified according to their ACCI and 114 patients with ACCI > 9 were chosen for comparison. While both groups were comparable in terms of age, the non-surgical treatment group had more female patients (p. = 0.026) and a smaller proportion of independent walkers (p < 0.001). The ACCI was higher for the surgical treatment group (p < 0.001). In-hospital mortality was similar (14.9% and 18.1% for the operative and non-surgical groups respectively, P. = 0.575). However, one-year mortality was significantly higher for the non-surgical group (48.2% vs. 67.0%, P. = 0.005). The rates of in-hospital complications and 1-year readmissions were similar. Operative treatment for fragility hip fracture reduces long-term mortality rates even in the more fragile patients, compared to non-surgical treatment.

Identifiants

pubmed: 31142435
pii: S0020-1383(19)30301-8
doi: 10.1016/j.injury.2019.05.022
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1347-1352

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Tal Frenkel Rutenberg (T)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel. Electronic address: tal_frenkel@hotmail.com.

Aseel Assaly (A)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Maria Vitenberg (M)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Shai Shemesh (S)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Alon Burg (A)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Barak Haviv (B)

Department of Orthopedics, Hasharon Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Steven Velkes (S)

Department of Orthopedics, Rabin Medical Center, Beilinson Hospital, Petah, Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH